Is telehealth as good as an in-person endocrinology visit?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
For most endocrine care that depends on history, lab interpretation and medication decisions, telehealth performs at least as well as in person care. The 2015 Cochrane review found lower HbA1c with telemedicine in diabetes trials. Telehealth cannot palpate a thyroid, scan a neck, examine a diabetic foot or draw blood, so those are done locally.
Telehealth and in person care are not competing on the same tasks. Endocrinology is a specialty where the diagnosis usually comes from the history, the trend across previous laboratory results, and a careful medication review. All three transfer completely to video. What does not transfer is anything requiring hands, a probe or a needle, and pretending otherwise is where remote care goes wrong.
What the evidence shows
The largest synthesis is the 2015 Cochrane review of interactive telemedicine, which pooled 93 randomised trials with 22,047 participants. In the diabetes trials, 16 studies with 2,768 participants, HbA1c was lower in the telemedicine groups than in usual care by a mean difference of 0.31 percentage points, and the reviewers graded that evidence as high certainty. Blood pressure also improved, with systolic pressure 4.33 mmHg lower and diastolic 2.75 mmHg lower than usual care. The American Diabetes Association's 2026 Standards of Care recommend that clinicians "consider offering DSMES via telehealth and/or digital interventions to address barriers to access and improve satisfaction."
Where the evidence stops
Two honest limits sit behind those numbers. Most trials tested telemedicine added to usual care rather than as a straight replacement for every visit, so the fair claim is that remote monitoring and remote consultation improve control, not that no one ever needs to be seen. And the same Cochrane review found no difference in all cause mortality in heart failure trials, with hospital admission results ranging from a 64 percent decrease to a 60 percent increase across studies. Telehealth is a delivery method. It does not make a treatment work better than the treatment.
| Task | Telehealth | Needs an in person visit |
|---|---|---|
| Adjusting levothyroxine, metformin or a GLP-1 dose | Yes | No |
| Interpreting labs, CGM data and home blood pressure | Yes | No |
| Assessing a thyroid nodule or new neck lump | No | Yes, examination and ultrasound |
| Diabetic foot examination and neuropathy testing | No | Yes, annually at minimum |
| Bone density, retinal screening, fine needle aspiration | No | Yes |
| Acute illness, chest pain, vomiting, confusion | No | Emergency care |
Who is better served in person
Some people should choose an in person endocrinologist. Anyone with a thyroid nodule under active surveillance, a diabetic foot problem, an unexplained lump, poorly controlled type 1 diabetes with hypoglycaemia unawareness, or a condition needing frequent examination will get better care from a physician who can examine them. The same applies if you have no reliable internet connection, no private space to talk, or no local laboratory you can reach easily.
The useful question is not which format is better in general. It is which parts of your own care need hands. If the answer is a yearly examination and a scan, a hybrid arrangement with a local physician plus remote specialist input usually beats either one alone.
The clinical detail
The Cochrane estimate for glycaemic control was a mean difference in HbA1c of 0.31 percentage points, 95 percent confidence interval 0.24 to 0.37 lower, at a median follow up of nine months, graded high certainty. Blood pressure effects were systolic 4.33 mmHg lower, 95 percent confidence interval 3.35 to 5.30, and diastolic 2.75 mmHg lower, 95 percent confidence interval 2.22 to 3.28, from four studies at moderate certainty.
Interpretation caveat: the included trials were heterogeneous in intensity, from scheduled video consultations to automated data transmission with clinician review, so the pooled effect describes a family of interventions rather than a single model of remote care.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD002098.pub2
- Standards of Care in Diabetes 2026, clinical guideline summary. American Diabetes Association, summary via Guideline Central
- 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes 2026. American Diabetes Association, Diabetes Care 49(Suppl 1):S13-S26. PMID 41358887
- Telehealth policy. U.S. Department of Health and Human Services, telehealth.hhs.gov
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.